Pfizer Pharmaceuticals Korea’s ‘Caduet Tab 10/20mg’ suspended sales for 45 days

A Pfizer Pharmaceuticals Korea’s combination drug for hypertension and hyperlipidemia, ‘Caduet Tab 10/20mg,’ has taken 45 days of administrative measure to suspend its sales activities.

On the 12^th, the Ministry of Food and Drug Safety(MFDS) announced it has exposed Pfizer Pharmaceuticals Korea’s acquisition of approval with misinformation; thus, it decided the administrative measure of sales ...